A contraceptive is a device or drug that prevents a woman from becoming pregnant.
The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population.
The global Contraceptive Drugs and Devices market size is projected to reach US$ 8873.2 million by 2027, from US$ 6844 million in 2020, at a CAGR of 4.4% during 2021-2027.
In terms of production side, this report researches the Contraceptive Drugs and Devices production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Contraceptive Drugs and Devices by regions (countries) and by Application.
The global Contraceptive Drugs and Devices market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Contraceptive Drugs and Devices market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Contraceptive Drugs and Devices markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Contraceptive Drugs and Devices market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Contraceptive Drugs and Devices market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Contraceptive Drugs and Devices market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Contraceptive Drugs and Devices market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Contraceptive Drugs and Devices market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Contraceptive Drugs and Devices market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Contraceptive Drugs and Devices market by each application segment for the same period.
This report includes the following manufacturers:
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Market Segment by Type
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Market Segment by Application
Hospitals
Pharmacies
Others
Research Methodology
To compile the detailed study of the global Contraceptive Drugs and Devices market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Contraceptive Drugs and Devices market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Contraceptive Drugs and Devices market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population.
The global Contraceptive Drugs and Devices market size is projected to reach US$ 8873.2 million by 2027, from US$ 6844 million in 2020, at a CAGR of 4.4% during 2021-2027.
In terms of production side, this report researches the Contraceptive Drugs and Devices production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Contraceptive Drugs and Devices by regions (countries) and by Application.
The global Contraceptive Drugs and Devices market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Contraceptive Drugs and Devices market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Contraceptive Drugs and Devices markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Contraceptive Drugs and Devices market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Contraceptive Drugs and Devices market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Contraceptive Drugs and Devices market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Contraceptive Drugs and Devices market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Contraceptive Drugs and Devices market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Contraceptive Drugs and Devices market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Contraceptive Drugs and Devices market by each application segment for the same period.
This report includes the following manufacturers:
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Market Segment by Type
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Market Segment by Application
Hospitals
Pharmacies
Others
Research Methodology
To compile the detailed study of the global Contraceptive Drugs and Devices market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Contraceptive Drugs and Devices market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Contraceptive Drugs and Devices market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by Type
1.2.2 Oral
1.2.3 Vaginal
1.2.4 Injectable Contraceptive Drugs
1.2.5 Male/Female Contraceptive Devices
1.3 Market Segment by Application
1.3.1 Global Contraceptive Drugs and Devices Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Contraceptive Drugs and Devices Market Size (2016-2027)
2.1.1 Global Contraceptive Drugs and Devices Revenue (2016-2027)
2.1.2 Global Contraceptive Drugs and Devices Sales (2016-2027)
2.2 Global Contraceptive Drugs and Devices Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Contraceptive Drugs and Devices Sales by Regions (2016-2021)
2.2.2 Global Contraceptive Drugs and Devices Revenue by Regions (2016-2021)
2.3 Global Contraceptive Drugs and Devices Market Size Forecast by Region
2.3.1 Global Contraceptive Drugs and Devices Sales Forecast by Region (2022-2027)
2.3.2 Global Contraceptive Drugs and Devices Revenue Forecast by Region (2022-2027)
2.4 Global Top Contraceptive Drugs and Devices Regions (Countries) Ranking by Market Size
2.5 Contraceptive Drugs and Devices Industry Trends
2.5.1 Contraceptive Drugs and Devices Market Trends
2.5.2 Contraceptive Drugs and Devices Market Drivers
2.5.3 Contraceptive Drugs and Devices Market Challenges
2.5.4 Contraceptive Drugs and Devices Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Contraceptive Drugs and Devices Manufacturers by Sales (2016-2021)
3.1.1 Global Contraceptive Drugs and Devices Sales by Manufacturers (2016-2021)
3.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Contraceptive Drugs and Devices Sales in 2020
3.2 Global Top Manufacturers Contraceptive Drugs and Devices by Revenue
3.2.1 Global Contraceptive Drugs and Devices Revenue by Manufacturers (2016-2021)
3.2.2 Top Contraceptive Drugs and Devices Manufacturers Covered: Ranking by Revenue
3.2.3 Global Contraceptive Drugs and Devices Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Contraceptive Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contraceptive Drugs and Devices as of 2020)
3.4 Global Contraceptive Drugs and Devices Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Contraceptive Drugs and Devices Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Contraceptive Drugs and Devices Market
3.7 Key Manufacturers Contraceptive Drugs and Devices Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Contraceptive Drugs and Devices Market Size by Type
4.1 Global Contraceptive Drugs and Devices Historic Market Review by Type (2016-2021)
4.1.1 Global Contraceptive Drugs and Devices Sales Market Share by Type (2016-2021)
4.1.2 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2016-2021)
4.1.3 Contraceptive Drugs and Devices Price by Type (2016-2021)
4.2 Global Contraceptive Drugs and Devices Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Contraceptive Drugs and Devices Sales Forecast by Type (2022-2027)
4.2.2 Global Contraceptive Drugs and Devices Revenue Forecast by Type (2022-2027)
4.2.3 Contraceptive Drugs and Devices Price Forecast by Type (2022-2027)
5 Global Contraceptive Drugs and Devices Market Size by Application
5.1 Global Contraceptive Drugs and Devices Historic Market Review by Application (2016-2021)
5.1.1 Global Contraceptive Drugs and Devices Sales Market Share by Application (2016-2021)
5.1.2 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2016-2021)
5.1.3 Contraceptive Drugs and Devices Price by Application (2016-2021)
5.2 Global Contraceptive Drugs and Devices Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Contraceptive Drugs and Devices Sales Forecast by Application (2022-2027)
5.2.2 Global Contraceptive Drugs and Devices Revenue Forecast by Application (2022-2027)
5.2.3 Contraceptive Drugs and Devices Price Forecast by Application (2022-2027)
6 North America
6.1 North America Contraceptive Drugs and Devices Sales Breakdown by Company
6.1.1 North America Contraceptive Drugs and Devices Sales by Company (2016-2027)
6.1.2 North America Contraceptive Drugs and Devices Revenue by Company (2016-2027)
6.2 North America Contraceptive Drugs and Devices Market Size by Type (2016-2027)
6.2.1 North America Contraceptive Drugs and Devices Sales by Type (2016-2027)
6.2.2 North America Contraceptive Drugs and Devices Revenue by Type (2016-2027)
6.3 North America Contraceptive Drugs and Devices Market Size by Application (2016-2027)
6.3.1 North America Contraceptive Drugs and Devices Sales by Application (2016-2027)
6.3.2 North America Contraceptive Drugs and Devices Revenue by Application (2016-2027)
6.4 North America Contraceptive Drugs and Devices Market Size by Country
6.4.1 North America Contraceptive Drugs and Devices Sales by Country (2016-2027)
6.4.2 North America Contraceptive Drugs and Devices Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Contraceptive Drugs and Devices Sales Breakdown by Company
7.1.1 Europe Contraceptive Drugs and Devices Sales by Company (2016-2027)
7.1.2 Europe Contraceptive Drugs and Devices Revenue by Company (2016-2027)
7.2 Europe Contraceptive Drugs and Devices Market Size by Type (2016-2027)
7.2.1 Europe Contraceptive Drugs and Devices Sales by Type (2016-2027)
7.2.2 Europe Contraceptive Drugs and Devices Revenue by Type (2016-2027)
7.3 Europe Contraceptive Drugs and Devices Market Size by Application (2016-2027)
7.3.1 Europe Contraceptive Drugs and Devices Sales by Application (2016-2027)
7.3.2 Europe Contraceptive Drugs and Devices Revenue by Application (2016-2027)
7.4 Europe Contraceptive Drugs and Devices Market Size by Country
7.4.1 Europe Contraceptive Drugs and Devices Sales by Country (2016-2027)
7.4.2 Europe Contraceptive Drugs and Devices Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Contraceptive Drugs and Devices Sales Breakdown by Company
8.1.1 Asia Pacific Contraceptive Drugs and Devices Sales by Company (2016-2027)
8.1.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Company (2016-2027)
8.2 Asia Pacific Contraceptive Drugs and Devices Market Size by Type (2016-2027)
8.2.1 Asia Pacific Contraceptive Drugs and Devices Sales by Type (2016-2027)
8.2.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Type (2016-2027)
8.3 Asia Pacific Contraceptive Drugs and Devices Market Size by Application (2016-2027)
8.3.1 Asia Pacific Contraceptive Drugs and Devices Sales by Application (2016-2027)
8.3.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Application (2016-2027)
8.4 Asia Pacific Contraceptive Drugs and Devices Market Size by Regions
8.4.1 Asia Pacific Contraceptive Drugs and Devices Sales by Regions
8.4.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Contraceptive Drugs and Devices Sales Breakdown by Company
9.1.1 Latin America Contraceptive Drugs and Devices Sales by Company (2016-2027)
9.1.2 Latin America Contraceptive Drugs and Devices Revenue by Company (2016-2027)
9.2 Latin America Contraceptive Drugs and Devices Market Size by Type (2016-2027)
9.2.1 Latin America Contraceptive Drugs and Devices Sales by Type (2016-2027)
9.2.2 Latin America Contraceptive Drugs and Devices Revenue by Type (2016-2027)
9.3 Latin America Contraceptive Drugs and Devices Market Size by Application (2016-2027)
9.3.1 Latin America Contraceptive Drugs and Devices Sales by Application (2016-2027)
9.3.2 Latin America Contraceptive Drugs and Devices Revenue by Application (2016-2027)
9.4 Latin America Contraceptive Drugs and Devices Market Size by Country
9.4.1 Latin America Contraceptive Drugs and Devices Sales by Country (2016-2027)
9.4.2 Latin America Contraceptive Drugs and Devices Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Contraceptive Drugs and Devices Sales Breakdown by Company
10.1.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Company (2016-2027)
10.1.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Company (2016-2027)
10.2 Middle East and Africa Contraceptive Drugs and Devices Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2016-2027)
10.2.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Type (2016-2027)
10.3 Middle East and Africa Contraceptive Drugs and Devices Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2016-2027)
10.3.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Application (2016-2027)
10.4 Middle East and Africa Contraceptive Drugs and Devices Market Size by Country
10.4.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2016-2027)
10.4.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Corporation Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Bayer Healthcare Contraceptive Drugs and Devices Products and Services
11.1.5 Bayer Healthcare Contraceptive Drugs and Devices SWOT Analysis
11.1.6 Bayer Healthcare Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Merck Contraceptive Drugs and Devices Products and Services
11.2.5 Merck Contraceptive Drugs and Devices SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Church & Dwight
11.3.1 Church & Dwight Corporation Information
11.3.2 Church & Dwight Overview
11.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Church & Dwight Contraceptive Drugs and Devices Products and Services
11.3.5 Church & Dwight Contraceptive Drugs and Devices SWOT Analysis
11.3.6 Church & Dwight Recent Developments
11.4 Warmer Chilcott
11.4.1 Warmer Chilcott Corporation Information
11.4.2 Warmer Chilcott Overview
11.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Warmer Chilcott Contraceptive Drugs and Devices Products and Services
11.4.5 Warmer Chilcott Contraceptive Drugs and Devices SWOT Analysis
11.4.6 Warmer Chilcott Recent Developments
11.5 Agile Therapeutics
11.5.1 Agile Therapeutics Corporation Information
11.5.2 Agile Therapeutics Overview
11.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Agile Therapeutics Contraceptive Drugs and Devices Products and Services
11.5.5 Agile Therapeutics Contraceptive Drugs and Devices SWOT Analysis
11.5.6 Agile Therapeutics Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Pfizer Contraceptive Drugs and Devices Products and Services
11.6.5 Pfizer Contraceptive Drugs and Devices SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 BioSante Pharmaceuticals
11.7.1 BioSante Pharmaceuticals Corporation Information
11.7.2 BioSante Pharmaceuticals Overview
11.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Products and Services
11.7.5 BioSante Pharmaceuticals Contraceptive Drugs and Devices SWOT Analysis
11.7.6 BioSante Pharmaceuticals Recent Developments
11.8 Mayer Laboratories
11.8.1 Mayer Laboratories Corporation Information
11.8.2 Mayer Laboratories Overview
11.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Mayer Laboratories Contraceptive Drugs and Devices Products and Services
11.8.5 Mayer Laboratories Contraceptive Drugs and Devices SWOT Analysis
11.8.6 Mayer Laboratories Recent Developments
11.9 Pantarhei Bioscience
11.9.1 Pantarhei Bioscience Corporation Information
11.9.2 Pantarhei Bioscience Overview
11.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Pantarhei Bioscience Contraceptive Drugs and Devices Products and Services
11.9.5 Pantarhei Bioscience Contraceptive Drugs and Devices SWOT Analysis
11.9.6 Pantarhei Bioscience Recent Developments
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Corporation Information
11.10.2 Teva Pharmaceutical Industries Overview
11.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Products and Services
11.10.5 Teva Pharmaceutical Industries Contraceptive Drugs and Devices SWOT Analysis
11.10.6 Teva Pharmaceutical Industries Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Contraceptive Drugs and Devices Value Chain Analysis
12.2 Contraceptive Drugs and Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Contraceptive Drugs and Devices Production Mode & Process
12.4 Contraceptive Drugs and Devices Sales and Marketing
12.4.1 Contraceptive Drugs and Devices Sales Channels
12.4.2 Contraceptive Drugs and Devices Distributors
12.5 Contraceptive Drugs and Devices Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by Type
1.2.2 Oral
1.2.3 Vaginal
1.2.4 Injectable Contraceptive Drugs
1.2.5 Male/Female Contraceptive Devices
1.3 Market Segment by Application
1.3.1 Global Contraceptive Drugs and Devices Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Contraceptive Drugs and Devices Market Size (2016-2027)
2.1.1 Global Contraceptive Drugs and Devices Revenue (2016-2027)
2.1.2 Global Contraceptive Drugs and Devices Sales (2016-2027)
2.2 Global Contraceptive Drugs and Devices Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Contraceptive Drugs and Devices Sales by Regions (2016-2021)
2.2.2 Global Contraceptive Drugs and Devices Revenue by Regions (2016-2021)
2.3 Global Contraceptive Drugs and Devices Market Size Forecast by Region
2.3.1 Global Contraceptive Drugs and Devices Sales Forecast by Region (2022-2027)
2.3.2 Global Contraceptive Drugs and Devices Revenue Forecast by Region (2022-2027)
2.4 Global Top Contraceptive Drugs and Devices Regions (Countries) Ranking by Market Size
2.5 Contraceptive Drugs and Devices Industry Trends
2.5.1 Contraceptive Drugs and Devices Market Trends
2.5.2 Contraceptive Drugs and Devices Market Drivers
2.5.3 Contraceptive Drugs and Devices Market Challenges
2.5.4 Contraceptive Drugs and Devices Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Contraceptive Drugs and Devices Manufacturers by Sales (2016-2021)
3.1.1 Global Contraceptive Drugs and Devices Sales by Manufacturers (2016-2021)
3.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Contraceptive Drugs and Devices Sales in 2020
3.2 Global Top Manufacturers Contraceptive Drugs and Devices by Revenue
3.2.1 Global Contraceptive Drugs and Devices Revenue by Manufacturers (2016-2021)
3.2.2 Top Contraceptive Drugs and Devices Manufacturers Covered: Ranking by Revenue
3.2.3 Global Contraceptive Drugs and Devices Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Contraceptive Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contraceptive Drugs and Devices as of 2020)
3.4 Global Contraceptive Drugs and Devices Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Contraceptive Drugs and Devices Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Contraceptive Drugs and Devices Market
3.7 Key Manufacturers Contraceptive Drugs and Devices Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Contraceptive Drugs and Devices Market Size by Type
4.1 Global Contraceptive Drugs and Devices Historic Market Review by Type (2016-2021)
4.1.1 Global Contraceptive Drugs and Devices Sales Market Share by Type (2016-2021)
4.1.2 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2016-2021)
4.1.3 Contraceptive Drugs and Devices Price by Type (2016-2021)
4.2 Global Contraceptive Drugs and Devices Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Contraceptive Drugs and Devices Sales Forecast by Type (2022-2027)
4.2.2 Global Contraceptive Drugs and Devices Revenue Forecast by Type (2022-2027)
4.2.3 Contraceptive Drugs and Devices Price Forecast by Type (2022-2027)
5 Global Contraceptive Drugs and Devices Market Size by Application
5.1 Global Contraceptive Drugs and Devices Historic Market Review by Application (2016-2021)
5.1.1 Global Contraceptive Drugs and Devices Sales Market Share by Application (2016-2021)
5.1.2 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2016-2021)
5.1.3 Contraceptive Drugs and Devices Price by Application (2016-2021)
5.2 Global Contraceptive Drugs and Devices Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Contraceptive Drugs and Devices Sales Forecast by Application (2022-2027)
5.2.2 Global Contraceptive Drugs and Devices Revenue Forecast by Application (2022-2027)
5.2.3 Contraceptive Drugs and Devices Price Forecast by Application (2022-2027)
6 North America
6.1 North America Contraceptive Drugs and Devices Sales Breakdown by Company
6.1.1 North America Contraceptive Drugs and Devices Sales by Company (2016-2027)
6.1.2 North America Contraceptive Drugs and Devices Revenue by Company (2016-2027)
6.2 North America Contraceptive Drugs and Devices Market Size by Type (2016-2027)
6.2.1 North America Contraceptive Drugs and Devices Sales by Type (2016-2027)
6.2.2 North America Contraceptive Drugs and Devices Revenue by Type (2016-2027)
6.3 North America Contraceptive Drugs and Devices Market Size by Application (2016-2027)
6.3.1 North America Contraceptive Drugs and Devices Sales by Application (2016-2027)
6.3.2 North America Contraceptive Drugs and Devices Revenue by Application (2016-2027)
6.4 North America Contraceptive Drugs and Devices Market Size by Country
6.4.1 North America Contraceptive Drugs and Devices Sales by Country (2016-2027)
6.4.2 North America Contraceptive Drugs and Devices Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Contraceptive Drugs and Devices Sales Breakdown by Company
7.1.1 Europe Contraceptive Drugs and Devices Sales by Company (2016-2027)
7.1.2 Europe Contraceptive Drugs and Devices Revenue by Company (2016-2027)
7.2 Europe Contraceptive Drugs and Devices Market Size by Type (2016-2027)
7.2.1 Europe Contraceptive Drugs and Devices Sales by Type (2016-2027)
7.2.2 Europe Contraceptive Drugs and Devices Revenue by Type (2016-2027)
7.3 Europe Contraceptive Drugs and Devices Market Size by Application (2016-2027)
7.3.1 Europe Contraceptive Drugs and Devices Sales by Application (2016-2027)
7.3.2 Europe Contraceptive Drugs and Devices Revenue by Application (2016-2027)
7.4 Europe Contraceptive Drugs and Devices Market Size by Country
7.4.1 Europe Contraceptive Drugs and Devices Sales by Country (2016-2027)
7.4.2 Europe Contraceptive Drugs and Devices Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Contraceptive Drugs and Devices Sales Breakdown by Company
8.1.1 Asia Pacific Contraceptive Drugs and Devices Sales by Company (2016-2027)
8.1.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Company (2016-2027)
8.2 Asia Pacific Contraceptive Drugs and Devices Market Size by Type (2016-2027)
8.2.1 Asia Pacific Contraceptive Drugs and Devices Sales by Type (2016-2027)
8.2.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Type (2016-2027)
8.3 Asia Pacific Contraceptive Drugs and Devices Market Size by Application (2016-2027)
8.3.1 Asia Pacific Contraceptive Drugs and Devices Sales by Application (2016-2027)
8.3.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Application (2016-2027)
8.4 Asia Pacific Contraceptive Drugs and Devices Market Size by Regions
8.4.1 Asia Pacific Contraceptive Drugs and Devices Sales by Regions
8.4.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Contraceptive Drugs and Devices Sales Breakdown by Company
9.1.1 Latin America Contraceptive Drugs and Devices Sales by Company (2016-2027)
9.1.2 Latin America Contraceptive Drugs and Devices Revenue by Company (2016-2027)
9.2 Latin America Contraceptive Drugs and Devices Market Size by Type (2016-2027)
9.2.1 Latin America Contraceptive Drugs and Devices Sales by Type (2016-2027)
9.2.2 Latin America Contraceptive Drugs and Devices Revenue by Type (2016-2027)
9.3 Latin America Contraceptive Drugs and Devices Market Size by Application (2016-2027)
9.3.1 Latin America Contraceptive Drugs and Devices Sales by Application (2016-2027)
9.3.2 Latin America Contraceptive Drugs and Devices Revenue by Application (2016-2027)
9.4 Latin America Contraceptive Drugs and Devices Market Size by Country
9.4.1 Latin America Contraceptive Drugs and Devices Sales by Country (2016-2027)
9.4.2 Latin America Contraceptive Drugs and Devices Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Contraceptive Drugs and Devices Sales Breakdown by Company
10.1.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Company (2016-2027)
10.1.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Company (2016-2027)
10.2 Middle East and Africa Contraceptive Drugs and Devices Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2016-2027)
10.2.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Type (2016-2027)
10.3 Middle East and Africa Contraceptive Drugs and Devices Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2016-2027)
10.3.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Application (2016-2027)
10.4 Middle East and Africa Contraceptive Drugs and Devices Market Size by Country
10.4.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2016-2027)
10.4.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Corporation Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Bayer Healthcare Contraceptive Drugs and Devices Products and Services
11.1.5 Bayer Healthcare Contraceptive Drugs and Devices SWOT Analysis
11.1.6 Bayer Healthcare Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Merck Contraceptive Drugs and Devices Products and Services
11.2.5 Merck Contraceptive Drugs and Devices SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Church & Dwight
11.3.1 Church & Dwight Corporation Information
11.3.2 Church & Dwight Overview
11.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Church & Dwight Contraceptive Drugs and Devices Products and Services
11.3.5 Church & Dwight Contraceptive Drugs and Devices SWOT Analysis
11.3.6 Church & Dwight Recent Developments
11.4 Warmer Chilcott
11.4.1 Warmer Chilcott Corporation Information
11.4.2 Warmer Chilcott Overview
11.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Warmer Chilcott Contraceptive Drugs and Devices Products and Services
11.4.5 Warmer Chilcott Contraceptive Drugs and Devices SWOT Analysis
11.4.6 Warmer Chilcott Recent Developments
11.5 Agile Therapeutics
11.5.1 Agile Therapeutics Corporation Information
11.5.2 Agile Therapeutics Overview
11.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Agile Therapeutics Contraceptive Drugs and Devices Products and Services
11.5.5 Agile Therapeutics Contraceptive Drugs and Devices SWOT Analysis
11.5.6 Agile Therapeutics Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Pfizer Contraceptive Drugs and Devices Products and Services
11.6.5 Pfizer Contraceptive Drugs and Devices SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 BioSante Pharmaceuticals
11.7.1 BioSante Pharmaceuticals Corporation Information
11.7.2 BioSante Pharmaceuticals Overview
11.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Products and Services
11.7.5 BioSante Pharmaceuticals Contraceptive Drugs and Devices SWOT Analysis
11.7.6 BioSante Pharmaceuticals Recent Developments
11.8 Mayer Laboratories
11.8.1 Mayer Laboratories Corporation Information
11.8.2 Mayer Laboratories Overview
11.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Mayer Laboratories Contraceptive Drugs and Devices Products and Services
11.8.5 Mayer Laboratories Contraceptive Drugs and Devices SWOT Analysis
11.8.6 Mayer Laboratories Recent Developments
11.9 Pantarhei Bioscience
11.9.1 Pantarhei Bioscience Corporation Information
11.9.2 Pantarhei Bioscience Overview
11.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Pantarhei Bioscience Contraceptive Drugs and Devices Products and Services
11.9.5 Pantarhei Bioscience Contraceptive Drugs and Devices SWOT Analysis
11.9.6 Pantarhei Bioscience Recent Developments
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Corporation Information
11.10.2 Teva Pharmaceutical Industries Overview
11.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Products and Services
11.10.5 Teva Pharmaceutical Industries Contraceptive Drugs and Devices SWOT Analysis
11.10.6 Teva Pharmaceutical Industries Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Contraceptive Drugs and Devices Value Chain Analysis
12.2 Contraceptive Drugs and Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Contraceptive Drugs and Devices Production Mode & Process
12.4 Contraceptive Drugs and Devices Sales and Marketing
12.4.1 Contraceptive Drugs and Devices Sales Channels
12.4.2 Contraceptive Drugs and Devices Distributors
12.5 Contraceptive Drugs and Devices Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
